Rafael Amado - 05 Jul 2022 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
EVP of R&D and CMO
Signature
Veer Bhavnagri as attorney-in-fact for Rafael Amado
Issuer symbol
ALLO
Transactions as of
05 Jul 2022
Net transactions value
-$22,880
Form type
4
Filing time
06 Jul 2022, 16:16:06 UTC
Previous filing
22 Jun 2022
Next filing
02 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALLO Common Stock Sale $22,880 -2,000 -0.37% $11.44 542,257 05 Jul 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in February 2022.